home / stock / slncf / slncf message board
Subject | By | Source | When |
---|---|---|---|
Emylers: SLNCF Financials 07/16/2014 14:39:30 Silence Therapeutics, Plc. Period Ending Total Revenue | Emylers | investorshangout | 07/16/2014 7:39:26 PM |
Silence Therapeutics plc Rating Reiterated by Canaccord Genuity (SLN) | Wildbilly | investorshub | 03/12/2014 5:26:04 PM |
Silence Therapeutics A Quieter Name In RNAi | Wildbilly | investorshub | 03/12/2014 5:18:37 PM |
Stock Tracker: Latest Silence Therapeutics (SLNCF) Headlines Global RNAi Drug Delivery Market 2014-2 | Stock_Tracker | investorshangout | 03/11/2014 1:26:09 PM |
chartguy89: SLNCF 6.30 Stock Charts $SLNCF 1 Month Chart | chartguy89 | investorshangout | 03/10/2014 1:16:26 AM |
chartguy89: SLNCF Stock Charts Last: +0.41 Saturday, March 1, 2014 at 4:17:33 PM $SLNCF 1 Mo | chartguy89 | investorshangout | 03/01/2014 9:17:45 PM |
Silence Therapeutics | gfp927z | investorshub | 06/01/2008 3:08:26 PM |
>>> AtuRNAi | gfp927z | investorshub | 06/01/2008 3:01:24 PM |
Silence Therapeutics | gfp927z | investorshub | 06/01/2008 3:01:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Silence Therapeutics Ord Company Name:
SLNCF Stock Symbol:
OTCMKTS Market:
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced the Company will partic...
Silence Therapeutics plc (Nasdaq: SLN) (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced that Alistair Gray, wh...
Published findings demonstrate zerlasiran was well-tolerated and significantly reduced Lp(a) after single and multiple dosing Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to ...